Waratah Capital Advisors Ltd. Acquires 26,468 Shares of BWX Technologies, Inc. $BWXT

Waratah Capital Advisors Ltd. boosted its holdings in shares of BWX Technologies, Inc. (NYSE:BWXT) by 382.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,392 shares of the technology company’s stock after purchasing an additional 26,468 shares during the period. Waratah Capital Advisors Ltd.’s holdings in BWX Technologies were worth $6,156,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Invesco Ltd. increased its stake in shares of BWX Technologies by 139.0% in the second quarter. Invesco Ltd. now owns 1,592,380 shares of the technology company’s stock valued at $229,398,000 after buying an additional 926,117 shares in the last quarter. Artisan Partners Limited Partnership bought a new position in shares of BWX Technologies in the second quarter worth about $183,859,000. Massachusetts Financial Services Co. MA lifted its position in shares of BWX Technologies by 26.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,159,033 shares of the technology company’s stock worth $213,691,000 after purchasing an additional 239,292 shares in the last quarter. Mawer Investment Management Ltd. grew its stake in shares of BWX Technologies by 15.6% during the second quarter. Mawer Investment Management Ltd. now owns 900,449 shares of the technology company’s stock valued at $129,719,000 after purchasing an additional 121,498 shares during the last quarter. Finally, Raymond James Financial Inc. increased its holdings in shares of BWX Technologies by 7.9% in the second quarter. Raymond James Financial Inc. now owns 707,602 shares of the technology company’s stock valued at $101,937,000 after purchasing an additional 51,998 shares in the last quarter. Institutional investors and hedge funds own 94.39% of the company’s stock.

Key BWX Technologies News

Here are the key news stories impacting BWX Technologies this week:

• Positive Sentiment: Q4 beat and healthy growth — BWXT reported Q4 EPS of $1.08 vs. a $0.91 consensus and revenue of $885.8M (above estimates); revenue rose ~19% year-over-year, and management called 2025 a record year. BWX Technologies Reports Fourth Quarter and Full Year 2025 Results
• Positive Sentiment: Upgraded 2026 guidance — BWXT set FY2026 EPS guidance of $4.55–$4.70 and revenue guidance around $3.8B, well above prior consensus, which is a primary catalyst supporting the stock rally. Guidance Press Release
• Positive Sentiment: Backlog and nuclear market momentum — management highlighted a large, growing backlog (reports cite ~50% backlog growth) and expanding commercial and defense nuclear work (SMRs, life‑extension contracts, enrichment awards), supporting multi‑year revenue visibility. BWX Technologies’ Stock Jumps. Its Nuclear Business Is Growing.
• Positive Sentiment: Analyst model changes — Northland Securities raised its Q2 and Q3 2026 EPS estimates and published an FY2027 view of $5.11; incremental analyst upward revisions support momentum (mixed on Q1). (Northland research note)
• Positive Sentiment: Dividend bump — BWXT raised its quarterly dividend to $0.27 (8% increase), a sign of confidence in cash flow that can attract income-focused investors. (Company announcement)
• Neutral Sentiment: Mixed near-term estimates — Northland trimmed its Q1 2026 estimate modestly (from $0.95 to $0.91) even as it lifted later‑year forecasts; a slight near-term pivot but overall outlook was upgraded.
• Neutral Sentiment: Positive press and analyst coverage — multiple outlets (Zacks, Benzinga) highlighted the beat and backlog; media attention helps visibility but is secondary to the results. Zacks Coverage
• Negative Sentiment: Valuation and expectations — the stock trades at a premium (P/E roughly mid‑50s on trailing numbers), so much of the upside depends on execution against elevated FY2026–FY2027 expectations; valuation could limit near‑term gains if guidance execution slips.

Insider Activity

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of the stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $203.26, for a total value of $2,032,600.00. Following the completion of the sale, the chief executive officer directly owned 177,594 shares in the company, valued at $36,097,756.44. This represents a 5.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.47% of the stock is owned by company insiders.

BWX Technologies Stock Up 3.1%

Shares of NYSE:BWXT opened at $204.49 on Wednesday. BWX Technologies, Inc. has a 52 week low of $84.21 and a 52 week high of $220.57. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.62 and a current ratio of 1.71. The company has a market capitalization of $18.70 billion, a PE ratio of 57.28, a PEG ratio of 3.19 and a beta of 0.84. The company has a 50 day moving average price of $196.27 and a two-hundred day moving average price of $186.97.

BWX Technologies (NYSE:BWXT) last announced its quarterly earnings results on Monday, February 23rd. The technology company reported $1.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.17. BWX Technologies had a net margin of 10.28% and a return on equity of 31.32%. The company had revenue of $885.84 million for the quarter, compared to analysts’ expectations of $837.47 million. During the same period last year, the firm posted $0.92 earnings per share. The business’s quarterly revenue was up 18.7% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.550-4.700 EPS. Analysts forecast that BWX Technologies, Inc. will post 3.23 earnings per share for the current year.

BWX Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 27th. Shareholders of record on Wednesday, March 11th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Wednesday, March 11th. This is a positive change from BWX Technologies’s previous quarterly dividend of $0.25. This represents a $1.08 dividend on an annualized basis and a yield of 0.5%. BWX Technologies’s payout ratio is presently 30.03%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on BWXT. Bank of America upped their price objective on BWX Technologies from $220.00 to $230.00 and gave the stock a “buy” rating in a report on Thursday, November 13th. Wall Street Zen upgraded BWX Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. BNP Paribas Exane assumed coverage on BWX Technologies in a report on Thursday, January 15th. They issued a “neutral” rating and a $215.00 price target on the stock. Weiss Ratings lowered BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 26th. Finally, Northland Securities set a $225.00 price objective on BWX Technologies in a report on Tuesday, November 4th. Three investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, BWX Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $199.20.

BWX Technologies Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.